Solventum Corporation (SOLV)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States Revenue	4.69B	4.67B	4.56B
United States Revenue Growth	0.45%	2.39%	-0.96%
International Revenue	3.57B	3.66B	3.70B
International Revenue Growth	-2.32%	-1.03%	2.81%
Revenue (Other)	1.00M	-	-
Revenue (Total)	8.26B	8.33B	8.25B
Revenue (Total) Growth	-0.76%	0.86%	0.69%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
MedSurg Revenue	4.89B	4.82B	4.64B
MedSurg Revenue Growth	1.58%	3.88%	0.11%
Dental Solutions Revenue	1.38B	1.35B	1.30B
Dental Solutions Revenue Growth	1.93%	4.17%	-2.56%
Health Information Systems Revenue	1.37B	1.36B	1.31B
Health Information Systems Revenue Growth	1.03%	4.13%	1.63%
Purification and Filtration Revenue	-	497.00M	709.00M
Purification and Filtration Revenue Growth	-	-29.90%	2.90%
Corporate and Unallocated Revenue	365.00M	302.00M	306.00M
Corporate and Unallocated Revenue Growth	20.86%	-1.31%	16.79%
Revenue (Other)	255.00M	-	1.00M
Revenue (Total)	8.26B	8.33B	8.25B
Revenue (Total) Growth	-0.76%	0.86%	0.69%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Product Revenue	6.27B	6.35B	6.35B
Product Revenue Growth	-1.32%	0.02%	0.83%
Software and Rental Revenue	2.00B	1.98B	1.91B
Software and Rental Revenue Growth	1.01%	3.67%	0.26%
Revenue (Total)	8.26B	8.33B	8.25B
Revenue (Total) Growth	-0.76%	0.86%	0.69%

EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
MedSurg Operating Income	765.00M	810.00M	887.00M
MedSurg Operating Income Growth	-5.56%	-8.68%	-19.87%
Dental Solutions Operating Income	354.00M	346.00M	350.00M
Dental Solutions Operating Income Growth	2.31%	-1.14%	-20.81%
Health Information Systems Operating Income	517.00M	496.00M	431.00M
Health Information Systems Operating Income Growth	4.23%	15.08%	1.89%
Purification and Filtration Operating Income	-	96.00M	74.00M
Purification and Filtration Operating Income Growth	-	29.73%	-33.33%
Corporate Operating Income	399.00M	432.00M	-706.00M
Corporate Operating Income Growth	-7.64%	-	-
Operating Income (Other)	74.00M	1.00M	-
Operating Income (Total)	2.11B	2.18B	1.04B
Operating Income (Total) Growth	-3.30%	110.52%	-38.77%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Organic Sales Growth	3.30%	1.20%

Data Source: Fiscal.ai Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error